Screener
Alamar Biosciences ALMR Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Alamar Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213424
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cost of revenue: | ||
| Cost of product revenue | 9,810 | 5,371 |
| Cost of service and other revenue | 1,768 | 1,331 |
| Total cost of revenue | 11,578 | 6,702 |
| Gross profit | 14,457 | 6,389 |
| Operating expenses: | ||
| Research and development | 13,017 | 8,302 |
| Selling, general and administrative | 13,787 | 6,640 |
Item 1. Financial Statements
FAQ
- What is Alamar Biosciences's total cost of revenue?
- Alamar Biosciences (ALMR) reported total cost of revenue of $11.58M in Q1 2026.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Alamar Biosciences's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude